CONNECTING Healthcare EXPERTISE

THE CLINICIAN EXCHANGE is a virtual exchange designed to pair specific clinical skillsets with specific industry initiatives.

EXCHANGE YOUR EXPERTISE

Learn how you can unlock the power of your expertise and experience to impact the healthcare industry in ways never before imagined

REGISTER NOWLEARN MORE

EXTEND, EXCEL…EXPLORE THE EXCHANGE

Learn how you can cost-effectively multiply your sales, education and R&D resources in an instant

REGISTER NOWLEARN MORE

COMMUNITY PORTAL

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

Nothing Fishy: Triglyceride Lowering With High-Dose EPA

Published: Tue, 13 Nov 2018 12:59:38 EST
How do the findings from the REDUCE-IT trial square with prior data on triglycerides and CVD? Prof Armitage sees a pattern.
theheart.org on Medscape

Brain Inflammation Seen for First Time in Fibromyalgia

Published: Tue, 13 Nov 2018 12:43:14 EST
The discovery may open the door to new treatments and bring comfort to those who have been told their symptoms are imaginary.
Medscape Medical News

Owl or Lark? Resting Energy Expenditure Varies Throughout Day

Published: Tue, 13 Nov 2018 11:54:08 EST
The energy expended during 'resting' activities, such as breathing and using the brain, varies depending on the time of day, and could explain the weight gain seen with shift work, say US scientists.
Medscape Medical News
Displaying results 1-3 (of 20)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

HEALTHCARE SUPPLIER NEWS

Bayer VP Alan Westwood to lead antimicrobial firm Matoke Pharma

Published: Tue, 13 Nov 2018 17:15:23 +0000
Former Bayer VP Alan Westwood has taken the reins of British antimicrobial biotech Matoke Pharma.

Deerfield sets up $80M to pursue protein degradation R&D at new Dana-Farber center

Published: Tue, 13 Nov 2018 14:36:19 +0000
Deerfield Management is committing up to $80 million to fund the creation of a new Center for Protein Degradation at the Dana-Farber Cancer Institute, with its sights on exploring a portfolio of targets in the field.

Roivant raises $200M, at $7B valuation, to add to startup roster

Published: Tue, 13 Nov 2018 13:50:50 +0000
Roivant Sciences has raised $200 million to roll out another round of startups. The financing, which comes 15 months after Roivant raised $1.1 billion, is tied to a $7 billion valuation for the fast-growing biotech umbrella organization.
Displaying results 1-3 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 

HAVE A QUESTION?

 Security code
1-800-4-the-clinx

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top